Three-month life expectancy as inclusion criterion for clinical trials in advanced pancreatic cancer: is it really a valid tool for patient selection?
Titel:
Three-month life expectancy as inclusion criterion for clinical trials in advanced pancreatic cancer: is it really a valid tool for patient selection?
Auteur:
Weiss, Lena Heinemann, Volker Fischer, Laura E. Gieseler, Frank Hoehler, Thomas Mayerle, Julia Quietzsch, Detlef Reinacher-Schick, Anke Schenk, Michael Seipelt, Gernot Siveke, Jens T. Stahl, Michael Vehling-Kaiser, Ursula Waldschmidt, Dirk T. Dorman, Klara Zhang, Danmei Westphalen, C. Benedikt von Bergwelt-Baildon, Michael Boeck, Stefan Haas, Michael